Incannex Healthcare IXHL
NASDAQ IXHL
$3.55 +0.11 (+3.20%)
As of: Aug 20, 2026 · 3:54 PM EDT

Incannex Healthcare (IXHL) Debt Ratio (2024 - 2025)

Incannex Healthcare (IXHL) posted Debt Ratio of 0.09 for Q1 2025, down 74.58% sequentially from 0.34 in Q4 2024.

Incannex Healthcare (IXHL) Debt Ratio (2024 - 2025) Analysis & Trends

Incannex Healthcare has reported Debt Ratio for 2 years, with the latest figure at 0.09 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -0.13
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn 0.42
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 0.60
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 0.32
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 0.38
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 0.29
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 0.12
10 Incannex Healthcare 42.87 Mn 42.87 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 0.09
Dec 31, 2024 0.34